Siemens Healthineers Management

As the company's top management body, the Managing Board is committed to serving the interests of the company and achieving sustainable growth in company value.

Managing Board

The members of the Managing Board are jointly responsible for the entire management of the company and decide on the basic issues of business policy and corporate strategy.

 

Dr. Bernd Montag

Bernd Montag, Ph.D., has been CEO of Siemens Healthineers since February 2015. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX.

Bernd Montag joined Siemens in 1995. He held positions in corporate quality management and sales in the hearing aid division before moving to imaging systems in 1999, where he served as a product manager for computed tomography and as the head of marketing for magnetic resonance business. In 2004, he assumed overall responsibility for computed tomography, and in 2008, he was named President of the Imaging & Therapy Division, which combined the overall business of diagnostic imaging and image-guided therapies.

Bernd Montag completed his studies in Physics at the Friedrich-Alexander-University, Erlangen-Nuremberg, and earned a Ph.D. in theoretical multi-particle physics. He was born in Munich, Germany, in 1969.

Dr. Jochen Schmitz

Jochen Schmitz, Ph.D., has been Chief Financial Officer (CFO) of Siemens Healthineers since December 2017. As of March 2018, the company is listed on the Frankfurt Stock Exchange as Siemens Healthineers AG (SHL). Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX.

Jochen Schmitz joined Siemens in 1996. He also holds a Ph.D. in the same field. After various positions with increasing responsibility in Corporate Finance in Germany he joined Siemens Healthcare in 2004, holding several executive finance positions in the Healthcare business in the USA and Germany. Among others he was CFO of the Diagnostics Division in USA and CFO of the Imaging & Therapy Systems Division in Germany until 2011. Afterwards, he had served for seven years as Corporate Vice President Controller of Siemens AG until he finally came back to Siemens Healthineers.

Jochen Schmitz completed his studies in Business Administration and Economics at the University of Augsburg. He was born in Moenchengladbach, Germany, in 1966.

Dr. Christoph Zindel

Christoph Zindel, M.D., has been a Member of the Managing Board of Siemens Healthineers since October 2019. As of March 2018, Siemens Healthineers AG (SHL) is listed on the Frankfurt Stock Exchange. Three months after its stock market debut, Siemens Healthineers entered the technology index TecDAX and in September that year Deutsche Börse also included the company in the mid-cap index MDAX.

Christoph Zindel joined the healthcare business in 1998 as Segment Manager and served in diverse management positions with increasing responsibility within the Magnetic Resonance Business Unit. From 2012 on he served as Senior Vice President of PETNET Solutions based in Knoxville, TN, United States before joining Beckman Coulter to head the Hematology and Urinanalysis Business Unit as Senior Vice President, based in Miami, FL, United States. After he returned to Siemens Healthineers in 2015, he served as Senior Vice President and General Manager of the Magnetic Resonance Business Line and became President of the Diagnostic Imaging business in 2018.

Christoph Zindel holds a Doctor of Medicine M.D. (Dr.) from the J.W. Goethe University Frankfurt, Germany. He was born in Stuttgart, Germany, in 1961.